Issue

Journal Browser
Forthcoming Issue
Current Issue
Volume 27, Issue 4 (April 2026)
Cardiovascular Outcomes in Patients With Diabetes and Chronic Liver Disease
Rev. Cardiovasc. Med. 2026, 27(4), 49626; https://doi.org/10.31083/RCM49626
(This article belongs to the Special Issue Cardiovascular Outcomes and Disease Management in Diabetic and Liver Patients)
Heart Transplant Outcomes in Chemotherapy-Induced vs. Non-Ischemic-Dilated Cardiomyopathy: Pediatric and Adult Recipients in the Ventricular Assist Device Era
Rev. Cardiovasc. Med. 2026, 27(4), 48253; https://doi.org/10.31083/RCM48253
Barriers to the Implementation of Acute Coronary Syndrome Guidelines in Healthcare: A Systematic Review
Rev. Cardiovasc. Med. 2026, 27(4), 46736; https://doi.org/10.31083/RCM46736
Exhaled Volatile Organic Compounds in Ischemic Cardiomyocytes: Signatures of Oxidative Stress!
Rev. Cardiovasc. Med. 2026, 27(4), 49046; https://doi.org/10.31083/RCM49046
Plaque Progression and Rupture in Obstructive Coronary Artery Disease: A Review of Current Imaging Modalities
Rev. Cardiovasc. Med. 2026, 27(4), 48015; https://doi.org/10.31083/RCM48015
Correlation Between Fat Attenuation Index and Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
Rev. Cardiovasc. Med. 2026, 27(4), 46683; https://doi.org/10.31083/RCM46683
Reply to Comment on “Combination of the Fibrosis-4 Index and Carbohydrate Antigen 125 to Predict Morbidity and Mortality in Acute Heart Failure”
Rev. Cardiovasc. Med. 2026, 27(4), 51120; https://doi.org/10.31083/RCM51120
A Comment on “Combination of the Fibrosis-4 Index and Carbohydrate Antigen 125 to Predict Morbidity and Mortality in Acute Heart Failure”
Rev. Cardiovasc. Med. 2026, 27(4), 50121; https://doi.org/10.31083/RCM50121
Early In-Hospital Initiation of Sodium–Glucose Cotransporter-2 Inhibitors After ST-Elevation Myocardial Infarction: A Clinical Review of Hemodynamic and Renal Safety
Rev. Cardiovasc. Med. 2026, 27(4), 48560; https://doi.org/10.31083/RCM48560
Predictors of In-Hospital Mortality From Infective Endocarditis in a Resource-Limited, War-Affected Tertiary Center
Rev. Cardiovasc. Med. 2026, 27(4), 49339; https://doi.org/10.31083/RCM49339
Advances in Epicardial Access for Ventricular Tachycardia Ablation: From Historical Techniques to Carbon Dioxide Insufflation
Rev. Cardiovasc. Med. 2026, 27(4), 47009; https://doi.org/10.31083/RCM47009
(This article belongs to the Special Issue Advancements in Catheter Ablation of Ventricular Tachycardias)
Extreme Weather Events, Air Pollution, and Cardiovascular Health: Mechanisms and Challenges
Rev. Cardiovasc. Med. 2026, 27(4), 47388; https://doi.org/10.31083/RCM47388
A Novel ApoB/ApoA1 Ratio-Integrated Nomogram to Predict Cardiogenic Shock After Acute Myocardial Infarction
Rev. Cardiovasc. Med. 2026, 27(4), 46493; https://doi.org/10.31083/RCM46493
Focus on Baseline LDL-C and Patient Risk, Not Drug Type: A Perspective on Alirocumab vs Evolocumab
Rev. Cardiovasc. Med. 2026, 27(4), 50430; https://doi.org/10.31083/RCM50430
Value of Thromboelastography as a Predictor of Postoperative Acute Respiratory Distress Syndrome in Patients With Acute Type A Aortic Dissection
Rev. Cardiovasc. Med. 2026, 27(4), 47295; https://doi.org/10.31083/RCM47295
The Association Between Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Severity
Rev. Cardiovasc. Med. 2026, 27(4), 46656; https://doi.org/10.31083/RCM46656
Supra-Annular Self-Expanding Versus Intra-Annular Balloon-Expandable Transcatheter Aortic Valve Implantation: A Meta-Analysis of Valve-Related Outcomes
Rev. Cardiovasc. Med. 2026, 27(4), 48459; https://doi.org/10.31083/RCM48459
An Overview of the Diagnostic and Treatment Strategies for Aortic Disease
Rev. Cardiovasc. Med. 2026, 27(4), 47202; https://doi.org/10.31083/RCM47202
A New and Robust Prognostic Biomarker for Mortality Risk Prediction in Dialysis Patients With Coronary Artery Disease: Red Cell Distribution Width-to-Albumin Ratio
Rev. Cardiovasc. Med. 2026, 27(4), 47939; https://doi.org/10.31083/RCM47939
Vericiguat: A New Horizon for Heart Failure Treatment
Rev. Cardiovasc. Med. 2026, 27(4), 48373; https://doi.org/10.31083/RCM48373
Mechanisms and Therapeutic Potential of Sodium–Glucose Cotransporter 2 Inhibitors in Heart Failure
Rev. Cardiovasc. Med. 2026, 27(4), 45833; https://doi.org/10.31083/RCM45833
(This article belongs to the Special Issue Advances of Drug Therapy in Heart Failure)
Effects of Maximal Fat Oxidation Exercise Training for Body Composition and Cardiovascular Risk Factors on College Students With Obesity
Rev. Cardiovasc. Med. 2026, 27(4), 46637; https://doi.org/10.31083/RCM46637
Nursing Care of Heart Failure With Preserved Ejection Fraction: Review
Rev. Cardiovasc. Med. 2026, 27(4), 47695; https://doi.org/10.31083/RCM47695
Association Between Vericiguat and Clinical Outcomes Across Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Rev. Cardiovasc. Med. 2026, 27(4), 49095; https://doi.org/10.31083/RCM49095
Long-Term Outcomes After Percutaneous Coronary Intervention According to the High-Sensitivity C-Reactive Protein-to-Albumin Ratio in Patients With Chronic Obstructive Pulmonary Disease in China
Rev. Cardiovasc. Med. 2026, 27(4), 46633; https://doi.org/10.31083/RCM46633
The Role of Glutathione Peroxidase 4 in Atherosclerosis: Role and Therapeutic Potential
Rev. Cardiovasc. Med. 2026, 27(4), 47324; https://doi.org/10.31083/RCM47324
Increased Vascular Endothelial Growth Factor Receptor 2 Levels Are Associated With a Higher Occurrence of Coronary Artery Disease in Patients With Obstructive Sleep Apnea
Rev. Cardiovasc. Med. 2026, 27(4), 46087; https://doi.org/10.31083/RCM46087
Advances in Diagnosis and Therapeutic Guidance for Acute Coronary Syndrome: A Narrative of A Precision Medicine Approach
Rev. Cardiovasc. Med. 2026, 27(4), 39947; https://doi.org/10.31083/RCM39947
DNA Methylation: A Key Epigenetic Regulator of Cardiovascular Diseases
Rev. Cardiovasc. Med. 2026, 27(4), 46194; https://doi.org/10.31083/RCM46194
Influence of Plasma Atherogenic Index on Coronary Artery Disease Severity: Insights From a Large-Scale Cohort Study in China
Rev. Cardiovasc. Med. 2026, 27(4), 45510; https://doi.org/10.31083/RCM45510
Astrocyte–Neuron Crosstalk in Hypertension: Mechanisms and Therapeutic Significance
Rev. Cardiovasc. Med. 2026, 27(4), 47764; https://doi.org/10.31083/RCM47764
Conduction Abnormalities After Transcatheter Aortic Valve Replacement: Comprehensive Review of Current Literature, Guidelines, and Clinical Practices
Rev. Cardiovasc. Med. 2026, 27(4), 48122; https://doi.org/10.31083/RCM48122
A New Paradigm for Atrial Fibrillation Ablation in Obesity Focusing on Substrate Remodeling and Patient-Centered Outcomes
Rev. Cardiovasc. Med. 2026, 27(4), 47591; https://doi.org/10.31083/RCM47591
Recent Advances in Understanding the Mechanisms of Therapy-Related Cardiovascular Events in Pediatric Hematologic Malignancies
Rev. Cardiovasc. Med. 2026, 27(4), 47353; https://doi.org/10.31083/RCM47353
Development of a Clinical Prediction Model for Acute Kidney Injury Among In-Hospital Cardiac Arrest Patients During Intensive Care Unit Hospitalization
Rev. Cardiovasc. Med. 2026, 27(4), 47434; https://doi.org/10.31083/RCM47434
(This article belongs to the Special Issue Cardiorenal Interactions: Biomarkers, Risk Stratification, and Therapeutic Strategies in Cardiovascular and Kidney Diseases)
When Sleep and Rhythm Collide: Amiodarone, Obstructive Sleep Apnoea, and Sinus Rhythm Maintenance After Cardioversion
Rev. Cardiovasc. Med. 2026, 27(4), 47485; https://doi.org/10.31083/RCM47485
Glucose and Lipid Metabolic Mechanisms in Vascular Aging and Related Therapeutic Strategies
Rev. Cardiovasc. Med. 2026, 27(4), 45053; https://doi.org/10.31083/RCM45053
Analysis of Morphological High-Risk Factors for Retrograde Type A Aortic Dissection
Rev. Cardiovasc. Med. 2026, 27(4), 42881; https://doi.org/10.31083/RCM42881
DNA Methylation and Fetal Programming of Cardiovascular Disease: From Congenital Heart Diseases to Adult Cardiovascular Dysfunction
Rev. Cardiovasc. Med. 2026, 27(4), 46174; https://doi.org/10.31083/RCM46174
Pericardial Inflammatory Mediators in Patients Undergoing Cardiac Surgery: Towards a Biomarker-Informed Clinical Practice
Rev. Cardiovasc. Med. 2026, 27(4), 49311; https://doi.org/10.31083/RCM49311
Volume 27, Issue 4 (2026)

Journal Browser
Forthcoming Issue
Current Issue
Article
Cardiovascular Outcomes in Patients With Diabetes and Chronic Liver Disease
Rev. Cardiovasc. Med. 2026, 27(4), 49626; https://doi.org/10.31083/RCM49626
(This article belongs to the Special Issue Cardiovascular Outcomes and Disease Management in Diabetic and Liver Patients)
Heart Transplant Outcomes in Chemotherapy-Induced vs. Non-Ischemic-Dilated Cardiomyopathy: Pediatric and Adult Recipients in the Ventricular Assist Device Era
Rev. Cardiovasc. Med. 2026, 27(4), 48253; https://doi.org/10.31083/RCM48253
Barriers to the Implementation of Acute Coronary Syndrome Guidelines in Healthcare: A Systematic Review
Rev. Cardiovasc. Med. 2026, 27(4), 46736; https://doi.org/10.31083/RCM46736
Exhaled Volatile Organic Compounds in Ischemic Cardiomyocytes: Signatures of Oxidative Stress!
Rev. Cardiovasc. Med. 2026, 27(4), 49046; https://doi.org/10.31083/RCM49046
Plaque Progression and Rupture in Obstructive Coronary Artery Disease: A Review of Current Imaging Modalities
Rev. Cardiovasc. Med. 2026, 27(4), 48015; https://doi.org/10.31083/RCM48015
Correlation Between Fat Attenuation Index and Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
Rev. Cardiovasc. Med. 2026, 27(4), 46683; https://doi.org/10.31083/RCM46683
Reply to Comment on “Combination of the Fibrosis-4 Index and Carbohydrate Antigen 125 to Predict Morbidity and Mortality in Acute Heart Failure”
Rev. Cardiovasc. Med. 2026, 27(4), 51120; https://doi.org/10.31083/RCM51120
A Comment on “Combination of the Fibrosis-4 Index and Carbohydrate Antigen 125 to Predict Morbidity and Mortality in Acute Heart Failure”
Rev. Cardiovasc. Med. 2026, 27(4), 50121; https://doi.org/10.31083/RCM50121
Early In-Hospital Initiation of Sodium–Glucose Cotransporter-2 Inhibitors After ST-Elevation Myocardial Infarction: A Clinical Review of Hemodynamic and Renal Safety
Rev. Cardiovasc. Med. 2026, 27(4), 48560; https://doi.org/10.31083/RCM48560
Predictors of In-Hospital Mortality From Infective Endocarditis in a Resource-Limited, War-Affected Tertiary Center
Rev. Cardiovasc. Med. 2026, 27(4), 49339; https://doi.org/10.31083/RCM49339
Advances in Epicardial Access for Ventricular Tachycardia Ablation: From Historical Techniques to Carbon Dioxide Insufflation
Rev. Cardiovasc. Med. 2026, 27(4), 47009; https://doi.org/10.31083/RCM47009
(This article belongs to the Special Issue Advancements in Catheter Ablation of Ventricular Tachycardias)
Extreme Weather Events, Air Pollution, and Cardiovascular Health: Mechanisms and Challenges
Rev. Cardiovasc. Med. 2026, 27(4), 47388; https://doi.org/10.31083/RCM47388
A Novel ApoB/ApoA1 Ratio-Integrated Nomogram to Predict Cardiogenic Shock After Acute Myocardial Infarction
Rev. Cardiovasc. Med. 2026, 27(4), 46493; https://doi.org/10.31083/RCM46493
Focus on Baseline LDL-C and Patient Risk, Not Drug Type: A Perspective on Alirocumab vs Evolocumab
Rev. Cardiovasc. Med. 2026, 27(4), 50430; https://doi.org/10.31083/RCM50430
Value of Thromboelastography as a Predictor of Postoperative Acute Respiratory Distress Syndrome in Patients With Acute Type A Aortic Dissection
Rev. Cardiovasc. Med. 2026, 27(4), 47295; https://doi.org/10.31083/RCM47295
The Association Between Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Severity
Rev. Cardiovasc. Med. 2026, 27(4), 46656; https://doi.org/10.31083/RCM46656
Supra-Annular Self-Expanding Versus Intra-Annular Balloon-Expandable Transcatheter Aortic Valve Implantation: A Meta-Analysis of Valve-Related Outcomes
Rev. Cardiovasc. Med. 2026, 27(4), 48459; https://doi.org/10.31083/RCM48459
An Overview of the Diagnostic and Treatment Strategies for Aortic Disease
Rev. Cardiovasc. Med. 2026, 27(4), 47202; https://doi.org/10.31083/RCM47202
A New and Robust Prognostic Biomarker for Mortality Risk Prediction in Dialysis Patients With Coronary Artery Disease: Red Cell Distribution Width-to-Albumin Ratio
Rev. Cardiovasc. Med. 2026, 27(4), 47939; https://doi.org/10.31083/RCM47939
Vericiguat: A New Horizon for Heart Failure Treatment
Rev. Cardiovasc. Med. 2026, 27(4), 48373; https://doi.org/10.31083/RCM48373
Mechanisms and Therapeutic Potential of Sodium–Glucose Cotransporter 2 Inhibitors in Heart Failure
Rev. Cardiovasc. Med. 2026, 27(4), 45833; https://doi.org/10.31083/RCM45833
(This article belongs to the Special Issue Advances of Drug Therapy in Heart Failure)
Effects of Maximal Fat Oxidation Exercise Training for Body Composition and Cardiovascular Risk Factors on College Students With Obesity
Rev. Cardiovasc. Med. 2026, 27(4), 46637; https://doi.org/10.31083/RCM46637
Nursing Care of Heart Failure With Preserved Ejection Fraction: Review
Rev. Cardiovasc. Med. 2026, 27(4), 47695; https://doi.org/10.31083/RCM47695
Association Between Vericiguat and Clinical Outcomes Across Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Rev. Cardiovasc. Med. 2026, 27(4), 49095; https://doi.org/10.31083/RCM49095
Long-Term Outcomes After Percutaneous Coronary Intervention According to the High-Sensitivity C-Reactive Protein-to-Albumin Ratio in Patients With Chronic Obstructive Pulmonary Disease in China
Rev. Cardiovasc. Med. 2026, 27(4), 46633; https://doi.org/10.31083/RCM46633
The Role of Glutathione Peroxidase 4 in Atherosclerosis: Role and Therapeutic Potential
Rev. Cardiovasc. Med. 2026, 27(4), 47324; https://doi.org/10.31083/RCM47324
Increased Vascular Endothelial Growth Factor Receptor 2 Levels Are Associated With a Higher Occurrence of Coronary Artery Disease in Patients With Obstructive Sleep Apnea
Rev. Cardiovasc. Med. 2026, 27(4), 46087; https://doi.org/10.31083/RCM46087
Advances in Diagnosis and Therapeutic Guidance for Acute Coronary Syndrome: A Narrative of A Precision Medicine Approach
Rev. Cardiovasc. Med. 2026, 27(4), 39947; https://doi.org/10.31083/RCM39947
DNA Methylation: A Key Epigenetic Regulator of Cardiovascular Diseases
Rev. Cardiovasc. Med. 2026, 27(4), 46194; https://doi.org/10.31083/RCM46194
Influence of Plasma Atherogenic Index on Coronary Artery Disease Severity: Insights From a Large-Scale Cohort Study in China
Rev. Cardiovasc. Med. 2026, 27(4), 45510; https://doi.org/10.31083/RCM45510
Astrocyte–Neuron Crosstalk in Hypertension: Mechanisms and Therapeutic Significance
Rev. Cardiovasc. Med. 2026, 27(4), 47764; https://doi.org/10.31083/RCM47764
Conduction Abnormalities After Transcatheter Aortic Valve Replacement: Comprehensive Review of Current Literature, Guidelines, and Clinical Practices
Rev. Cardiovasc. Med. 2026, 27(4), 48122; https://doi.org/10.31083/RCM48122
A New Paradigm for Atrial Fibrillation Ablation in Obesity Focusing on Substrate Remodeling and Patient-Centered Outcomes
Rev. Cardiovasc. Med. 2026, 27(4), 47591; https://doi.org/10.31083/RCM47591
Recent Advances in Understanding the Mechanisms of Therapy-Related Cardiovascular Events in Pediatric Hematologic Malignancies
Rev. Cardiovasc. Med. 2026, 27(4), 47353; https://doi.org/10.31083/RCM47353
Development of a Clinical Prediction Model for Acute Kidney Injury Among In-Hospital Cardiac Arrest Patients During Intensive Care Unit Hospitalization
Rev. Cardiovasc. Med. 2026, 27(4), 47434; https://doi.org/10.31083/RCM47434
(This article belongs to the Special Issue Cardiorenal Interactions: Biomarkers, Risk Stratification, and Therapeutic Strategies in Cardiovascular and Kidney Diseases)
When Sleep and Rhythm Collide: Amiodarone, Obstructive Sleep Apnoea, and Sinus Rhythm Maintenance After Cardioversion
Rev. Cardiovasc. Med. 2026, 27(4), 47485; https://doi.org/10.31083/RCM47485
Glucose and Lipid Metabolic Mechanisms in Vascular Aging and Related Therapeutic Strategies
Rev. Cardiovasc. Med. 2026, 27(4), 45053; https://doi.org/10.31083/RCM45053
Analysis of Morphological High-Risk Factors for Retrograde Type A Aortic Dissection
Rev. Cardiovasc. Med. 2026, 27(4), 42881; https://doi.org/10.31083/RCM42881
DNA Methylation and Fetal Programming of Cardiovascular Disease: From Congenital Heart Diseases to Adult Cardiovascular Dysfunction
Rev. Cardiovasc. Med. 2026, 27(4), 46174; https://doi.org/10.31083/RCM46174
Pericardial Inflammatory Mediators in Patients Undergoing Cardiac Surgery: Towards a Biomarker-Informed Clinical Practice
Rev. Cardiovasc. Med. 2026, 27(4), 49311; https://doi.org/10.31083/RCM49311
